StockWatch
·
Q2 FY-2027 RESULTS · FLUOROCHEM

GFL Q2 FY27: Consolidated PAT +42% YoY to ₹240 Cr, margin holds near 27%, tops Street view

PAT +42% YoY · revenue +45.5% · margins compressing · beat vs street

Q2 FY27 resultsFLUOROCHEMGujarat Fluorochemicals Ltd03 Nov 2026 · 3 min read
Revenue

₹1,760 Cr

+45.5% YoY

PAT (consolidated)

₹240 Cr

+42% YoY

Net margin

13.56%

-1.2pp YoY

EPS

₹22.11

Gujarat Fluorochemicals' consolidated Q2 FY27 print clears the bar the Street set going in. Revenue came in at ₹1,760 Cr against a pre-result expectation of ₹1,500–1,550 Cr, and consolidated PAT of ₹240 Cr beat the ₹200–230 Cr range analysts had pencilled in (per our pre-result preview, citing S&P Global/TipRanks/SimplyWall.st consensus). The bigger surprise is on margins: EBITDA of ₹473 Cr works out to a 26.9% margin, comfortably above the 20–22% the Street was bracing for after Q1's margin miss, and essentially flat against Q1's 27.0% — so the 'margin recovery' question our preview posed is better read as margin stabilization than a sharp rebound. Consolidated basic EPS was ₹22.11 (standalone ₹28.12).

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹1,760 Cr+10.8%+45.5%
Expenses₹1,431 Cr+11.1%+47.5%
PAT₹240 Cr+9.6%+42%
Net margin13.56%-0.1pp-1.2pp
EPS₹22.11+9.6%+35.6%

The headline YoY PAT growth needs a caveat. On a reported basis PAT is up 42% from the year-ago quarter's restated ₹169 Cr; our stored year-ago record of ₹179 Cr (EPS ₹16.31) is the figure as originally reported, before this filing's Note 4 restated it down by ₹10 Cr after the EV Products subsidiary reversed a ₹24 Cr deferred-tax asset and reclassified ₹22 Cr of capital work-in-progress. Against that originally-reported base, YoY PAT growth reads closer to 34%. Either way, growth is driven by the core Chemicals segment, where revenue rose 43% YoY to ₹1,743 Cr and EBITDA to ₹505 Cr; margins there are still down from a year ago (consolidated EBITDA margin 26.9% vs 29.6% in Q2 FY26), consistent with the cost pressure the preview flagged. A new ₹7 Cr fair-value loss on the EV subsidiary's Series A CCPS also sat in this quarter's finance costs — strip it out and PBT would be closer to ₹346 Cr versus the reported ₹339 Cr.

₹
4,124.754,311.654,498.554,685.454,872.354,506.407-3108-2409-1610-0911-03Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹4,506.4, up 3.5% over the past month of trading.

₹ Cr
089.6179.2268.8184Q1 FY26rev ₹1,281 Cr179Q2 FY26rev ₹1,210 Cr102Q3 FY26rev ₹1,136 Cr109Q4 FY26rev ₹1,369 Cr219Q1 FY27rev ₹1,588 Cr240Q2 FY27rev ₹1,760 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 3 consecutive quarters; revenue is at a 6-quarter high.

What management guided (1 FY-2027 call)
Fluoropolymer 17–20% annual growth reaffirmed (Q1 delivered 15%, mix-driven). Battery materials expected 3-digit revenue by Q4 FY27, significant ramp FY28 onwards. FY27 capex ₹3,100 Cr (₹2,300 Cr EV, ₹800 Cr chemicals) on track; target ₹6,000 Cr over multi-years.

On guidance, the filing doesn't break out fluoropolymer-specific volumes, so the 17–20% annual fluoropolymer growth target reaffirmed at the Q1 call can't be directly graded this quarter. The EV Products segment, management's other guided marker, posted ₹41 Cr of revenue (up from ₹29 Cr in Q1) with the EBITDA loss widening to -₹32 Cr from -₹30 Cr — still well short of the 3-digit-crore quarterly revenue management has guided for Q4 FY27, though two quarters remain. H1 consolidated capex (cash, including CWIP movements) of ₹841 Cr tracks toward but is still well under a third of the ₹3,100 Cr FY27 target (₹2,300 Cr EV, ₹800 Cr chemicals) management laid out, implying a much heavier H2 spend. No management press release or commentary accompanied this filing, so there is no fresh management quote to check against the numbers.

  • W1

    EV Products revenue run-rate vs management's 3-digit-crore (₹100 Cr+) quarterly target for Q4 FY27 (currently ₹41 Cr, up from ₹29 Cr in Q1).

  • W2

    EV Products EBITDA loss trend (-₹32 Cr this quarter, -₹30 Cr in Q1, -₹23 Cr a year ago) — management guides to a 'significant ramp' only from FY28, so losses are expected to keep widening before turning.

  • W3

    FY27 capex pacing against the ₹3,100 Cr guided total (₹2,300 Cr EV Products, ₹800 Cr chemicals) — H1 cash capex (incl. CWIP) was ₹841 Cr, implying a steep H2 ramp to hit the full-year number.

Informational and educational content only. Not investment advice.